A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis. (AHR CB)
An Open-label, Multicenter, Single-group Study to Evaluate the Effects of Long-term Use of Mucinex® in Patients With Stable Chronic Bronchitis.
Sponsor: American Health Research
Listed as NCT05843669, this PHASE4 trial focuses on Chronic Bronchitis and remains completed. Sponsored by American Health Research, it has been updated 8 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Dec 2025 — Present [monthly]
Completed PHASE4
-
Sep 2025 — Dec 2025 [monthly]
Completed PHASE4
-
Jun 2025 — Sep 2025 [monthly]
Completed PHASE4
-
Mar 2025 — Jun 2025 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Sep 2024 — Mar 2025 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Aug 2023 — Jul 2024 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jun 2023 — Aug 2023 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- American Health Research
- Vitaccess Ltd
For direct contact, visit the study record on ClinicalTrials.gov .